SUDEEPPHRMSudeep Pharma Limited

Rs 983▲ +1.74%
Market closedEquity EOD 26 Oct
Compare
52-week rangeThe lowest and highest prices the stock traded at over the last year, from each day's intraday low and high. The marker is today's close: 0% means it sits at the year's low, 100% at the high. It describes where the price is, not where it is going.53.7% up the range
Rs 524Rs 1,378
SUDEEPPHRM price
Daily candles, adjusted for splits and bonus issues so a corporate action does not show as a crash. Pick a window from one month to the full history, add indicators, or open it full screen.
EOD 26 Oct
IndicatorsVolume

Loading SUDEEPPHRM price...

At a glance
Each figure is shown against the company's sector (the track: the dot is this company, the tick is the sector middle) and, where we hold the yearly filings, against its own recent years (the small trend line).
Market capWhat the whole company is worth on the stock market today: share price times the number of shares. It measures size, not quality.
Rs 11,103 cr
Larger than 81% of 64 peers
sector middle Rs 2,182 cr
P/EPrice to earnings: how many rupees investors pay for each rupee of profit the company made over the last twelve months. Compare it with similar companies rather than reading it alone.
59.7x
Higher than 80% of 56 peers
sector middle 26.9x
Price to bookPrice to book: the share price divided by the shareholders' money per share in the latest balance sheet. Around 1 means the market values the company close to its book value.
12.6x
Higher than 98% of 64 peers
sector middle 2.7x
ROEReturn on equity: the year's profit as a percentage of the shareholders' money in the business. It shows how much the company earns on what its owners have put in.
20.4%
Higher than 90% of 60 peers
sector middle 9.7%
ROCEReturn on capital employed: operating profit as a percentage of all the long-term money in the business, owners' and lenders'. It shows how well the company uses its capital, whatever the mix of debt.
24.2%
Higher than 90% of 61 peers
sector middle 10.8%
Debt to equityBorrowings divided by shareholders' money. 0 means no borrowings; 1 means it owes as much as its owners have put in. Not shown for banks and lenders, whose borrowing is their business.
0.17
Lower than 56% of 64 peers
sector middle 0.22
Dividend yieldDividends paid over the last year as a percentage of the company's market value: roughly what Rs 100 of shares paid out in cash.
0.0%
Lower than 75% of 64 peers
sector middle 0.3%

Peers are the listed companies in the exchange's own industry group: Specialty Chemicals. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

What the numbers say
Short lines written by fixed rules from the company's own filings and shareholding. A line appears only when the figures cross the rule (for example sales growing three years running), and each names the numbers behind it. Nothing here is a view on whether to own the share.

Latest quarterIn the quarter to June 2026 (results filed 4 Aug 2026), sales was Rs 158 cr and profit was Rs 40.6 cr.

Nothing in the filings we hold crosses one of our rules yet. Each rule needs a few complete years of results, so recently listed companies often show nothing here.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

How the share moved on results
For each quarterly result we hold: the change from the share's close on the last trading day before the filing to its close on the first trading day after it. Results can land during market hours or after the close, and this window covers both. It shows what happened, not what will happen next time.

Over the last 3 results, the share rose on 2 and fell on 1, and moved by 3% or more on 2.

Q2 FY26Q1 FY27

Q1 FY27: results filed 4 Aug 2026. The share went from its close on 3 Aug 2026 to its close on 5 Aug 2026 +10.53%.

Fundamentals
Trailing-twelve-month valuation, margins and growth from the company's own filings.
as of 2026-06-30
P/E (TTM)
59.7
PEG
-
EPS (TTM)
Rs 16.5
Net margin
27.2%
Rev growth YoY
-
Profit growth YoY
-
TTM revenue
Rs 676 Cr
TTM net profit
Rs 184 Cr
What it owns, and how that is paid for
Straight from the March balance sheet in the company's annual filing. Both bars are the whole balance sheet: what the company owns, and where the money for it came from.
as at 2026-03-31

At FY26 it owned Rs 1,175 Cr of assets. Its owners funded 76% of that and borrowings 13%.

What it owns
34%
18%
19%
10%
12%
Plant, property and projects402 Cr
Goodwill and intangibles68 Cr
Inventory216 Cr
Owed by customers228 Cr
Cash and bank115 Cr
Everything else146 Cr
How that is paid for
76%
13%
Shareholders898 Cr
Borrowings148 Cr
Owed to suppliers68 Cr
Other liabilities60 Cr
Cash and equivalents
Rs 27 Cr
Net debt
Rs 122 Cr
Current ratio
3.09x
short-term assets per rupee due soon
Book value / share
Rs 78
Return on assets
15.6%
EV / EBITDA
44.8x

From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.

Where the cash went
Profit is an accounting figure; cash flow is what actually moved. Cash from running the business, plus or minus what was spent on or received from investments, plus or minus what came from or went to lenders and shareholders, equals the change in cash.

In FY26 the business itself brought in Rs 70 Cr, spent Rs 118 Cr on plant and equipment, and cash fell by Rs 10 Cr over the year.

From running the business
+70 Cr
Spent on or received from investing
-327 Cr
From or to lenders and shareholders
+247 Cr
Net change in cash
-10 Cr

Full financial year to 2026-03-31, from the company's cash flow statement.

Against its sector
Where this stock sits within its own sector on each measure. The marker is its position in the peer group and the notch is the sector median. A position is a fact about the cohort, not a view on the stock.
Specialty Chemicals · 90
P/E59.72vs 26.92 median
Cheapest: PLASTIBLEN 10Priciest: OAL 647.47
Net margin27.18%vs 6.63% median
Lowest: DIAMINESQ -24.79%Highest: SUDEEPPHRM 27.18%

Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.

Peers side by side
Every company in the same NSE industry group that we hold figures for, largest first. Tap any heading to sort by it. The same figures as the At a glance tiles, worked out the same way for every company.
Specialty Chemicals · 40 shown
Company
PIDILITIND
Pidilite Industries Limited
1.50 L cr56.9x13.9x24.2%28.5%0.0117.4%+21.3%1.01%
SRF
SRF Limited
69,362 cr30.4x4.5x14.9%-0.3412.5%+34.7%0.38%
FLUOROCHEM
Gujarat Fluorochemicals Limited
46,168 cr75.4x5.9x7.7%10.2%0.2811.5%+24.0%0.07%
NAVINFLUOR
Navin Fluorine International Limited
39,306 cr49.8x9.9x19.9%18.7%0.3121.7%+44.1%0.17%
DEEPAKNTR
Deepak Nitrite Limited
19,676 cr25.1x3.4x13.3%10.8%0.269.1%+36.4%0.52%
AETHER
Aether Industries Limited
19,529 cr82.8x8.0x9.6%12.2%0.1819.2%+52.4%0.00%
ATUL
Atul Limited
15,762 cr20.4x2.4x11.8%-0.0211.3%+20.9%0.47%
AARTIIND
Aarti Industries Limited
15,539 cr29.3x2.6x8.9%8.5%0.835.9%+42.5%0.23%
FINEORG
Fine Organic Industries Limited
15,328 cr35.0x5.8x16.4%20.2%0.0217.7%+18.0%0.22%
BASF
BASF India Limited
13,174 cr20.5x3.3x16.3%13.1%0.004.0%+24.5%0.66%
PRIVISCL
Privi Speciality Chemicals Limited
13,109 cr49.4x9.3x23.7%25.1%0.7012.8%+19.2%0.15%
ANURAS
Anupam Rasayan India Limited
12,802 cr73.1x3.8x4.9%7.5%0.398.9%+34.8%0.12%
SUDEEPPHRM
Sudeep Pharma Limited
11,103 cr59.7x12.6x20.4%24.2%0.1727.2%-0.00%
VINATIORGA
Vinati Organics Limited
10,964 cr24.4x3.5x14.2%17.7%0.0018.8%+28.4%0.71%
JUBLINGREA
Jubilant Ingrevia Limited
9,581 cr31.2x3.1x9.9%10.8%0.256.6%+25.3%0.83%
ALKYLAMINE
Alkyl Amines Chemicals Limited
8,373 cr37.2x5.5x14.7%14.6%0.0013.6%+30.2%0.61%
CLEAN
Clean Science and Technology Limited
7,835 cr33.6x5.0x14.7%19.2%0.0023.7%+10.5%0.81%
GALAXYSURF
Galaxy Surfactants Limited
7,710 cr21.8x2.8x12.9%12.7%0.066.2%+39.4%0.27%
NEOGEN
Neogen Chemicals Limited
5,955 cr163.7x7.3x4.4%6.8%1.633.8%+34.0%0.04%
BALAMINES
Balaji Amines Limited
5,882 cr28.7x3.0x9.8%10.2%0.0613.8%+27.2%0.61%
ACI
Archean Chemical Industries Limited
5,782 cr59.4x3.0x5.0%7.8%0.248.6%+11.9%0.64%
YASHO
Yasho Industries Limited
4,542 cr78.8x10.2x13.0%11.3%1.226.1%+54.9%0.01%
FOSECOIND
Foseco India Limited
4,285 cr42.6x4.0x9.4%-0.0013.2%+47.2%0.37%
LXCHEM
Laxmi Organic Industries Limited
4,257 cr33.9x2.1x6.3%4.4%0.274.0%+39.8%0.33%
EPIGRAL
Epigral Limited
3,820 cr14.1x1.7x12.2%14.8%0.2510.3%+16.3%0.48%
VISHNU
Vishnu Chemicals Limited
3,772 cr25.1x3.5x13.9%16.2%0.498.8%+24.9%0.05%
TATVA
Tatva Chintan Pharma Chem Limited
3,667 cr71.3x4.7x6.6%7.6%0.159.2%+43.0%0.06%
STYRENIX
Styrenix Performance Materials Limited
3,370 cr12.3x2.5x20.0%12.8%0.237.8%+7.1%2.80%
CHEMPLASTS
Chemplast Sanmar Limited
3,009 cr-1.7x-22.3%-4.1%1.11-9.2%+2.3%0.00%
JUBLCPL
Jubilant Agri and Consumer Products Limited
2,910 cr22.7x6.3x28.2%34.9%0.066.6%+18.4%0.00%
DDEVPLSTIK
Ddev Plastiks Industries Limited
2,473 cr11.6x2.4x21.1%28.9%0.056.7%+28.6%0.94%
NOCIL
NOCIL Limited
2,420 cr36.7x1.4x3.7%4.1%0.004.8%+19.9%1.40%
ROSSARI
Rossari Biotech Limited
2,251 cr14.9x1.7x11.3%15.3%0.315.9%+28.2%0.12%
OAL
Oriental Aromatics Limited
2,114 cr647.5x3.2x0.8%6.2%0.610.5%+15.2%0.08%
SHK
S H Kelkar and Company Limited
1,749 cr19.6x1.3x6.5%9.6%0.623.6%+14.1%1.58%
CAMLINFINE
Camlin Fine Sciences Limited
1,600 cr378.6x1.5x0.1%2.9%0.670.0%+22.7%0.00%
VIDHIING
Vidhi Specialty Food Ingredients Limited
1,557 cr29.2x4.8x16.2%20.9%0.1812.1%+66.4%1.45%
PAUSHAKLTD
Paushak Limited
1,501 cr-3.1x-8.7%0.16--0.40%
PLATIND
Platinum Industries Limited
1,242 cr24.6x2.8x10.8%14.9%0.0111.1%-5.6%0.00%
VALIANTORG
Valiant Organics Limited
1,221 cr22.5x1.6x7.2%7.0%0.337.1%+13.3%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

The business
Sales and net profit from the company's own filings, by financial year or by quarter. Hover any bar for that period's complete figures including operating margin and the change against the comparable earlier period. The single TTM figure above is the sum of the last four quarters.
4 quarters
RevenueRs 158 Cr
Net profitRs 41 Cr
Sep 254 quarters filedJun 26

Each bar is one quarter as filed with the exchange, newest on the right, so the seasonal shape of the business is visible rather than smoothed away. Hover any quarter for its full figures and the change against the same quarter a year earlier. Revenue and profit are drawn on separate scales because they differ by an order of magnitude; reading one against the other would be misleading.

Dividends paid
Cash paid per share, from the exchange's corporate-action record, restated to today's share count across bonuses and splits. Dates shown are ex-dates: you must own the shares before that date to receive the payment.
0.15% yield
Rs 150 / year
Paid 1 of 1 yrs
on Rs 1 lakh at today's price · 0.15% yield · Rs 1.5/share
What each year paid, on Rs 1 lakh
153
26*
* 2026 so far - more may still be declared this year

2026 has paid Rs 1.50 per share, about Rs 153 on Rs 1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.

Large institutional deals
Bulk and block deals reported by the exchange, where a single large trade is disclosed along with the counterparty's name. Only deals above the exchange's disclosure threshold appear here.
last 8
DatePartySideQtyPriceValue
2026-08-04GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIOBUY11,76,472850Rs 100 Cr
2026-08-04GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIOBUY11,76,472850Rs 100 Cr
2026-08-04NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIISELL6,14,112850Rs 52.2 Cr
2026-08-04NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIISELL6,14,112850Rs 52.2 Cr
2026-08-04NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIIASELL5,62,360850Rs 47.8 Cr
2026-07-24SBI MUTUAL FUNDBUY20,00,000800Rs 160 Cr
2026-07-24SBI MUTUAL FUNDBUY20,00,000800Rs 160 Cr
2026-07-24NUVAMA CROSSOVER OPPORTUNITIES FUND - SERIES IIISELL10,60,000800Rs 84.8 Cr
Technical snapshot
Momentum, trend and delivery-based conviction from the actual price and volume history.
EOD 26 Oct
RSI (14) - momentum
36.3Neutral
0 oversold3070overbought 100
Delivery % - genuine buying vs churn
38.4%Near average
today 38.4%20d avg 53.4%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50-DMA
-13.57%
vs 200-DMA
+20.94%
1-month
-18.06%
3-month
+19.13%
1-year
-
Realized vol (30d)
48.2%
Insider trading disclosures
Promoter, director and other insider trades in the company's own shares, as disclosed to the exchange under SEBI's insider-trading regulations - usually within a few days of the transaction.
last 18 months

Insider trading data unavailable.

Recent announcements
The company's own filings to the exchange - results, board meetings, investor calls - with a link to the source document.
last 6 months

Announcements unavailable.

Want to test a strategy on SUDEEPPHRM?

Backtest an equity strategy on real market data, free - no card needed.

Start free

Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.